Japan Lifeline Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Keisuke Suzuki

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	19yrs
Participación del CEO	14.9%
Permanencia media de la dirección	5.5yrs
Promedio de permanencia en la Junta Directiva	6yrs

Actualizaciones recientes de la dirección

Recent updates

Japan Lifeline Co., Ltd. Just Missed EPS By 6.2%: Here's What Analysts Think Will Happen Next

May 06

Japan Lifeline (TSE:7575) Is Increasing Its Dividend To ¥42.00

Mar 02

CEO

Keisuke Suzuki (71 yo)

19yrs

Permanencia

Mr. Keisuke Suzuki has been the President of Japan Lifeline Co., Ltd. since June 2005 and serves as its Chief Executive Officer. Mr. Suzuki served as Vice President of Japan Lifeline Co., Ltd., since April...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Keisuke Suzuki	President	19yrs	sin datos	14.93% ¥ 12.4b
Atsuhiro Suzuki	Senior EVP & COO	no data	sin datos	0.48% ¥ 394.5m
Kenji Yamada	Senior VP	less than a year	sin datos	0.035% ¥ 28.7m
Takayuki Kuronuma	Consultant	5yrs	sin datos	sin datos
Toru Takamiya	VP, Executive Manager of R&D and Manufacturing Headquarters & Director	7yrs	sin datos	0.0040% ¥ 3.3m
Tadashi Idei	VP, Executive Manager of Regulatory Affairs Headquarters & Director	7yrs	sin datos	0.0053% ¥ 4.4m
Yumiko Hoshiba	VP, Sr. Manager of Gr. Aff. Dep. of Corp. Admi. Headq.	6yrs	sin datos	0.019% ¥ 15.5m
Tatsuya Murase	SVP, Executive Manager of General Business Headquarters & CVG Business Unit and Director	3.9yrs	sin datos	0.0013% ¥ 1.1m
Shigeki Kitayama	Operating Officer & Senior Manager of EP Department of Arrhythmia Business Unit	no data	sin datos	sin datos
Naohiro Nakada	Operating Officer	no data	sin datos	sin datos
Takahiko Suzuki	Operating Officer	no data	sin datos	sin datos
Takeyoshi Egawa	VP, Senior Manager of Business Administration Department & Director	less than a year	sin datos	sin datos

5.5yrs

Permanencia media

60yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 7575 es experimentado (5.4 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Keisuke Suzuki	President	19yrs	sin datos	14.93% ¥ 12.4b
Kenji Yamada	Senior VP	no data	sin datos	0.035% ¥ 28.7m
Toru Takamiya	VP, Executive Manager of R&D and Manufacturing Headquarters & Director	7yrs	sin datos	0.0040% ¥ 3.3m
Tadashi Idei	VP, Executive Manager of Regulatory Affairs Headquarters & Director	7yrs	sin datos	0.0053% ¥ 4.4m
Yumiko Hoshiba	VP, Sr. Manager of Gr. Aff. Dep. of Corp. Admi. Headq.	6yrs	sin datos	0.019% ¥ 15.5m
Tatsuya Murase	SVP, Executive Manager of General Business Headquarters & CVG Business Unit and Director	2yrs	sin datos	0.0013% ¥ 1.1m
Takeyoshi Egawa	VP, Senior Manager of Business Administration Department & Director	less than a year	sin datos	sin datos
Fumihiro Sasaki	Independent Outside Director	12yrs	sin datos	0.0040% ¥ 3.3m
Yoshiaki Ikei	Independent Outside Director	7yrs	sin datos	0.0040% ¥ 3.3m
Yutaka Karigome	Independent Outside Director	3yrs	sin datos	sin datos
Masahiko Nakamura	Outside Independent Director	3yrs	sin datos	sin datos
Daizo Asari	Independent Outside Director	3yrs	sin datos	0.0040% ¥ 3.3m

6.0yrs

Permanencia media

60.5yo

Promedio de edad

Junta con experiencia: La junta directiva de 7575 se considera experimentada (5.8 años de antigüedad promedio).

Japan Lifeline Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Japan Lifeline Co., Ltd., Annual General Meeting, Jun 26, 2024

Japan Lifeline Co., Ltd. Announces the Appointment of Nobuo Takahashi as Operating Officer, Associate Executive Manager of CVG Business Unit

Japan Lifeline Co., Ltd. Announces Management Changes

Japan Lifeline Co., Ltd., Annual General Meeting, Jun 28, 2023

Japan Lifeline Announces Changes in Board of Directors, Effective June 28, 2023

Japan Lifeline Co., Ltd. Announces Executive Changes, Effective October 1, 2022 Respectively

Recent updates

Japan Lifeline Co., Ltd. to Report Q1, 2025 Results on Jul 31, 2024

Japan Lifeline Co., Ltd. Proposes Dividend for the Fiscal Year Ended March 31, 2024

Japan Lifeline Co., Ltd. Just Missed EPS By 6.2%: Here's What Analysts Think Will Happen Next

Full year 2024 earnings: EPS misses analyst expectations

Japan Lifeline Co., Ltd., Annual General Meeting, Jun 26, 2024

Upcoming dividend of JP¥42.00 per share

Japan Lifeline (TSE:7575) Is Increasing Its Dividend To ¥42.00

Japan Lifeline Co., Ltd. to Report Q4, 2024 Results on May 01, 2024

Price target increased by 11% to JP¥1,400

Third quarter 2024 earnings released: EPS: JP¥28.32 (vs JP¥11.15 in 3Q 2023)

Japan Lifeline Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2024

Japan Lifeline Co., Ltd. Announces the Appointment of Nobuo Takahashi as Operating Officer, Associate Executive Manager of CVG Business Unit

Price target increased by 11% to JP¥1,258

New major risk - Revenue and earnings growth

Japan Lifeline Co., Ltd. Announces Management Changes

Japan Lifeline Co., Ltd. to Report Q3, 2024 Results on Feb 02, 2024

Second quarter 2024 earnings released: EPS: JP¥22.31 (vs JP¥22.54 in 2Q 2023)

Price target increased by 13% to JP¥1,280

Now 23% undervalued

Now 21% undervalued

Japan Lifeline Co., Ltd. Announces That It Will Start Selling A New Lineup of Its Proprietary Open Stent Graft Product Frozenix Partial ET from August 2023

Now 23% undervalued

First quarter 2024 earnings released: EPS: JP¥30.02 (vs JP¥24.73 in 1Q 2023)

Japan Lifeline Co., Ltd. to Report Q2, 2024 Results on Nov 06, 2023

Full year 2023 earnings: EPS misses analyst expectations

Japan Lifeline Co., Ltd., Annual General Meeting, Jun 28, 2023

Japan Lifeline Announces Changes in Board of Directors, Effective June 28, 2023

Upcoming dividend of JP¥38.00 per share at 4.1% yield

Japan Lifeline Co., Ltd. Revises Financial Forecast of Consolidated Financial Results for the Year Ending March 31, 2023

Third quarter 2023 earnings released: EPS: JP¥11.15 (vs JP¥24.01 in 3Q 2022)

Now 21% undervalued after recent price drop

Second quarter 2023 earnings released: EPS: JP¥23.64 (vs JP¥23.49 in 2Q 2022)

Second quarter 2023 earnings released: EPS: JP¥23.64 (vs JP¥23.49 in 2Q 2022)

Japan Lifeline Co., Ltd. Provides Year End Dividend Guidance for the Year Ending March 31, 2023

Consensus forecasts updated

Japan Lifeline Co., Ltd. Launches Series of In-House Products for Biliary-Pancreatic Endoscopy

Japan Lifeline Co., Ltd. Announces Executive Changes, Effective October 1, 2022 Respectively

Japan Lifeline Co., Ltd. to Report Q3, 2023 Results on Feb 01, 2023

First quarter 2023 earnings released: EPS: JP¥24.73 (vs JP¥21.17 in 1Q 2022)

Japan Lifeline Co., Ltd. Provides Consolidated Earnings Guidance for Six Months Ending September 30, 2022 and Year Ending March 31, 2023

Japan Lifeline Co., Ltd. to Report Q2, 2023 Results on Nov 02, 2022

Price target decreased to JP¥1,120

Japan Lifeline Co., Ltd. Announces Dividend for Year Ended March 31, 2022, Effective Date Is June 29, 2022

Full year 2022 earnings: EPS in line with expectations, revenues disappoint

Japan Lifeline Co., Ltd., Annual General Meeting, Jun 28, 2022

Consensus EPS estimates fall by 12%

Japan Lifeline Co., Ltd. Appoints Shigeki Kitayama as Operating Officer

Upcoming dividend of JP¥38.00 per share

Third quarter 2022 earnings: EPS misses analyst expectations

Japan Lifeline Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2022

Price target decreased to JP¥1,500

Japan Lifeline Co., Ltd. Provides Earnings Guidance for the Six Months Ending September 30, 2021 and Full Year of Ending March 31, 2022

First quarter 2022 earnings released: EPS JP¥21.17 (vs JP¥10.53 in 1Q 2021)

Metcela Inc. and Japan Lifeline Co., Ltd. Announces Initiation of Phase I Clinical Trial of MTC001 in Patients with Chronic Ischemic Heart Failure

VP, GM of CRM Business Division & Director Osamu Watanabe has left the company

Japan Lifeline Receives Regulatory Approval for HeartLight X3

Japan Lifeline Co., Ltd. Receives Regulatory Approval for Abdominal Stent Graft Alto

Full year 2021 earnings released: EPS JP¥24.90 (vs JP¥96.55 in FY 2020)

Japan Lifeline Co., Ltd. Provides Year End Cash Dividend Guidance for the Year Ending March 31, 2022

Consensus forecasts updated

Upcoming dividend of JP¥49.00 per share

New 90-day low: JP¥1,365

Cardiofocus, Inc. Announces Expanded Partnership with Japan Lifeline Co., Ltd

Third quarter 2021 earnings released: JP¥31.57 loss per share (vs JP¥27.44 profit in 3Q 2020)

Revenue and earnings miss expectations

Analysts update estimates

New 90-day high: JP¥1,633

Japan Lifeline Co., Ltd. Announces Changes in Personnel

New 90-day high: JP¥1,515